Institution
Ottawa Hospital Research Institute
Also known as: Institut de recherche de l'hôpital d'Ottawa · IRHO · OHRI
- 77running trials
- 32closed trials
- 20,149publications (OpenAlex)
Running trials
Recruiting
Enrolling by invitation
Recruiting
An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
Recruiting
Recruiting
Recruiting
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Recruiting
Recruiting
Active, not recruiting
Recruiting
International Care Bundle Evaluation in Cerebral Hemorrhage Research
Recruiting
Recruiting
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Recruiting
Recruiting
Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
Recruiting
VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
Recruiting
Recruiting
Recruiting
Emergency Medicine Pulmonary Embolism Testing Multicentre Study
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters
Recruiting
TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion
Recruiting
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Active, not recruiting
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Active, not recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Recruiting
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Active, not recruiting
Active, not recruiting
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Recruiting
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism
Showing 50 of 77.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke5 recruiting
- Childhood cancers3 recruiting
- Deep vein thrombosis and pulmonary embolism3 recruiting
- Melanoma3 recruiting
- Heart failure2 recruiting
- Multiple myeloma2 recruiting
- Myotonic dystrophy2 recruiting
- Prostate cancer2 recruiting
- ALS (motor neurone disease)1 recruiting
- Ankylosing spondylitis1 recruiting
- Bipolar disorder1 recruiting
- Chronic kidney disease1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- COPD1 recruiting
- Coronary artery disease1 recruiting
- Crohn's disease1 recruiting
- Head and neck cancer1 recruiting
- Hodgkin lymphoma1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Migraine1 recruiting
- Myasthenia gravis1 recruiting
- Neuroendocrine tumours1 recruiting
- Osteoarthritis1 recruiting
- Pancreatic cancer1 recruiting
- Peripheral artery disease1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Sarcoma1 recruiting
- Sickle cell disease1 recruiting
- Thalassaemia1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1
Terminated
Completed
Completed
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Recruiting
Completed
Recruiting
Completed
Completed
Completed
Withdrawn
Terminated
Completed
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator
Completed
Motion Capture as a Tool for the Assessment of Laparoscopic Performance
Completed
Completed
Completed
Completed
Completed
Completed
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Completed
Completed
NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Completed
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
Completed
Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer
Completed
Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours
Completed
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Completed
Completed
Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Completed
Completed
Completed
Registry name variants (22)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
77 trials
The Ottawa Hospital Research Institute
Ottawa, Ontario K1Y 4E9
10 trials
Ottawa Hospital Research Institute (OHRI)
Ottawa, Ontario K1H 8L6
3 trials
NCT06667453A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Contact: Jessica MacGregor
NCT06204809Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1
NCT04812366Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Contact: Pascale Juneau
Ottawa Hospital Research Institute
Toronto, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute
Ottawa, Ontario K1Y 4E9
1 trial
Ottawa Hospital Research Institute (Ottawa University)
Ottawa, Ontario
1 trial
Ottawa Hospital Research Institute (Site 0109)
Ottawa, Ontario K1H 8L6
1 trial
Ottawa Hospital Research Institute- The Ottawa Hospital
Ottawa, Ontario K1H8L6
1 trial
NCT05029063Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters
Contact: Amanda Pecarskie
Ottawa Hospital Research Institute - Vision Research Centre
Ottawa, Ontario K1H8L6
1 trial
NCT05101928Ozurdex Monotherapy Trial
The Ottawa Hospital - Ottawa Hospital Research Institute (OHRI)
Ottawa, Ontario
1 trial
The Ottawa Hospital | The Ottawa Hospital Research Institute - Neurology - Ottawa Stroke Program
Ottawa, Ontario K1Y4E9
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Deep vein thrombosis and pulmonary embolism94 works · 7 trials
- Bipolar disorder21 works · 1 trial
- Hepatitis C14 works · 0 trials
- Psoriatic arthritis12 works · 3 trials
- Spinal muscular atrophy6 works · 0 trials
- Antiphospholipid syndrome4 works · 0 trials
Institution data: ROR 05jtef216 (CC0-1.0)Updated 15 Nov 2026